RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced the appointment of a new chief financial officer and corporate secretary. The company named François C. Desrosiers, B. Com (Spec.) and FCSI, as Rryah CFO and corporate; the appointment is subject to approval by the Canadian Securities Exchange (“CSE”). Desrosiers brings impressive experience in senior executive leadership roles to his new role with RYAH. He has served as cofounder, president, CEO and director at Northcore Resources Inc.; corporate secretary and officer at Prime Blockchain Inc., whic merged with RYAH Group; and founder, president, CEO and director at AntOro Resources. He also served in key executive roles at Melkior Resources Inc., NIKRON Technologies Inc. and Orbite Exploration VSPA. In addition, he has served as consultant for a number of private and public companies and was a registered representative and officer at securities brokerage companies in Montreal and Ottawa. “RYAH is extremely fortunate to have someone of François’ high caliber and extensive experience to contribute to our financial leadership and success,” said RYAH CEO Dr. Dave Richards in the press release.
To view the full press release, visit https://ibn.fm/rgYAM
About RYAH Group Inc.
RYAH is a big data and technology company enabling valuable AI-powered predictive analytics of the efficacy of plant-based medicines and other nutraceuticals administered through its range of innovative IoT-connected medical devices including inhalers, patches and pens. RYAH’s robust big data platform, the only one of its kind in this space, aggregates and analyzes HIPAA-compliant patient data, helping doctors and patients personalize treatments, control dosages, and better predict and monitor outcomes. The data and derived insights are also highly valuable for hospitals, clinicians, medical scientists, insurance providers, dispensaries, licensed growers, producers and pharmaceutical companies, and to monitor and manage formulation effects on patients based on dosages, strains, demographics, specific conditions and a range of other factors. Exciting new directions under CEO Dr. David Richards’ leadership include R&D in the realm of blockchain, NFTs and cryptocurrency that will pave the way toward successful commercialization of RYAH’s big-data assets. Through the above along with a relentless focus on innovation and track record of developing win-win collaborative partnerships within relevant industries, RYAH is continuously building a unique and highly valuable IP portfolio. For more information about the company, please visit www.RyahGroup.com.
NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://ibn.fm/RYAH
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.InvestorWire.com
InvestorWire is part of the InvestorBrandNetwork.